Cargando…

Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping

BACKGROUND: Identification of Streptococcus pneumoniae (Spn) and its more than 90 serotypes is routinely conducted by culture and Quellung reactions. Quantitative (q)PCR reactions have been developed for molecular detection, including a pan-Spn lytA assay, and assays targeting 78 serotypes. Reaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Fuminori, Sonaty, Griffin, Klugman, Keith, Vidal, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630758/
http://dx.doi.org/10.1093/ofid/ofx163.1622
_version_ 1783269285767938048
author Sakai, Fuminori
Sonaty, Griffin
Klugman, Keith
Vidal, Jorge
author_facet Sakai, Fuminori
Sonaty, Griffin
Klugman, Keith
Vidal, Jorge
author_sort Sakai, Fuminori
collection PubMed
description BACKGROUND: Identification of Streptococcus pneumoniae (Spn) and its more than 90 serotypes is routinely conducted by culture and Quellung reactions. Quantitative (q)PCR reactions have been developed for molecular detection, including a pan-Spn lytA assay, and assays targeting 78 serotypes. Reactions require genomic DNA from every target to prepare standards, which can be time consuming. In this study we have developed a synthetic DNA molecule as a surrogate for genomic DNA and present new single-plex qPCR reactions to increase molecular detection to 94 pneumococcal serotypes. METHODS: Single-plex qPCR reactions (N = 11) that detect 16 pneumococcal serotypes/serogroups were developed and concentration of primer and probe optimized to obtain a recommended efficiency between 90 and 110%. Specificity for the target serotype/serogroup of these new reactions was investigated using a collection of strains belonging to our laboratory and strains kindly donated by the “StrepLab” at CDC. A synthetic DNA (NUversa, ~8.2 kb) was then engineered to contain all available qPCR targets for serotyping and lytA. NUversa was cloned into pUC57-Amp-modified to generate pNUversa (~10.2 kb). Standards prepared from pNUversa and NUversa were compared against standards made out of genomic DNA. RESULTS: Specificity of these new reactions was confirmed, and after optimization, the obtained limit of detection (LOD) was between 2 and 20 genome equivalents/reaction. Molecular studies demonstrated that linearity [NUversa (R(2)>0.982); pNUversa (R(2)>0.991)] and efficiency of qPCR reactions using synthetic DNA were similar to those utilizing chromosomal DNA (R(2)>0.981). Quantification, however, with plasmid pNUversa (Y-Int=43.0 ± 1.12) was affected whereas that using synthetic NUversa (Y-Int=40.3 ± 1.08) was comparable to genomic DNA (Y-Int=39.9 ± 0.62). CONCLUSION: We validated new single-plex reactions that, together with published qPCR reactions, now make possible to detect and quantify 94 pneumococcal serotypes/serogroups. NUversa can be utilized as a control in most, if not all, published single-plex qPCR reactions, for the identification (i.e., detection), and quantification (i.e., genome equivalents) of pneumococcal serotypes. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5630758
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56307582017-11-07 Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping Sakai, Fuminori Sonaty, Griffin Klugman, Keith Vidal, Jorge Open Forum Infect Dis Abstracts BACKGROUND: Identification of Streptococcus pneumoniae (Spn) and its more than 90 serotypes is routinely conducted by culture and Quellung reactions. Quantitative (q)PCR reactions have been developed for molecular detection, including a pan-Spn lytA assay, and assays targeting 78 serotypes. Reactions require genomic DNA from every target to prepare standards, which can be time consuming. In this study we have developed a synthetic DNA molecule as a surrogate for genomic DNA and present new single-plex qPCR reactions to increase molecular detection to 94 pneumococcal serotypes. METHODS: Single-plex qPCR reactions (N = 11) that detect 16 pneumococcal serotypes/serogroups were developed and concentration of primer and probe optimized to obtain a recommended efficiency between 90 and 110%. Specificity for the target serotype/serogroup of these new reactions was investigated using a collection of strains belonging to our laboratory and strains kindly donated by the “StrepLab” at CDC. A synthetic DNA (NUversa, ~8.2 kb) was then engineered to contain all available qPCR targets for serotyping and lytA. NUversa was cloned into pUC57-Amp-modified to generate pNUversa (~10.2 kb). Standards prepared from pNUversa and NUversa were compared against standards made out of genomic DNA. RESULTS: Specificity of these new reactions was confirmed, and after optimization, the obtained limit of detection (LOD) was between 2 and 20 genome equivalents/reaction. Molecular studies demonstrated that linearity [NUversa (R(2)>0.982); pNUversa (R(2)>0.991)] and efficiency of qPCR reactions using synthetic DNA were similar to those utilizing chromosomal DNA (R(2)>0.981). Quantification, however, with plasmid pNUversa (Y-Int=43.0 ± 1.12) was affected whereas that using synthetic NUversa (Y-Int=40.3 ± 1.08) was comparable to genomic DNA (Y-Int=39.9 ± 0.62). CONCLUSION: We validated new single-plex reactions that, together with published qPCR reactions, now make possible to detect and quantify 94 pneumococcal serotypes/serogroups. NUversa can be utilized as a control in most, if not all, published single-plex qPCR reactions, for the identification (i.e., detection), and quantification (i.e., genome equivalents) of pneumococcal serotypes. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5630758/ http://dx.doi.org/10.1093/ofid/ofx163.1622 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Sakai, Fuminori
Sonaty, Griffin
Klugman, Keith
Vidal, Jorge
Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping
title Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping
title_full Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping
title_fullStr Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping
title_full_unstemmed Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping
title_short Development and Characterization of a Synthetic DNA, NUversa, to Be Used as a Standard in All Quantitative PCR Reactions for Molecular Pneumococcal Serotyping
title_sort development and characterization of a synthetic dna, nuversa, to be used as a standard in all quantitative pcr reactions for molecular pneumococcal serotyping
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630758/
http://dx.doi.org/10.1093/ofid/ofx163.1622
work_keys_str_mv AT sakaifuminori developmentandcharacterizationofasyntheticdnanuversatobeusedasastandardinallquantitativepcrreactionsformolecularpneumococcalserotyping
AT sonatygriffin developmentandcharacterizationofasyntheticdnanuversatobeusedasastandardinallquantitativepcrreactionsformolecularpneumococcalserotyping
AT klugmankeith developmentandcharacterizationofasyntheticdnanuversatobeusedasastandardinallquantitativepcrreactionsformolecularpneumococcalserotyping
AT vidaljorge developmentandcharacterizationofasyntheticdnanuversatobeusedasastandardinallquantitativepcrreactionsformolecularpneumococcalserotyping